J&J discontinues Alzheimer's study of tau-targeting antibody (Firstwordpharma Press Release) - Nov 23, 2025 - "J&J plans to share a full evaluation of the results, which it said 'underscore the deep complexity of the disease,' with the scientific community' in due course."
Trial termination • Alzheimer's Disease
|